Clinical trials are run at the Vancouver Prostate Centre and at our partner institution, the BC Cancer Agency. To learn more about prostate cancer trials and other GU cancer trials visit the BC Cancer Agency website.

A list of clinical trials that are currently recruiting patients at the Vancouver Prostate Centre are outlined below.  You can click on the links for detailed information where you’ll be taken to a registry federally and privately supported clinical trials conducted in Canada, the United States, and around the world. These websites give you information about a trial's purpose, who may participate, locations, and phone numbers for more details.

Note, this information should be used in conjunction with advice from health care professionals. Patients must be referred by their physician to be able to participate in a clinical trial.

Prostate cancer prevention

Diffusion Tensor Imaging and Contrast Enhanced Dynamic MRI in Prostate Cancer Diagnosis

Prostate cancer

PREVAIL: A Multinational Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer Who Have Failed Androgen Deprivation Therapy - click here for more info

Randomized Controlled Trial of POMELLA™ Extract in Prostate Cancer Patients Scheduled for Surgery - click here for more info

A Randomized Double-Blind, Placebo-Controlled Phase III Study of Early versus Standard Zoledronic Acid to Prevent Skeletal Related Events in Men with Prostate Cancer Metastatic to Bone – CALGB 90202/NCIC PRC.2 - click here for more info

A Randomized, Open Label, Multicenter, Phase III, 2-Arm Study of Androgen Deprivation with Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Subjects with a Rising PSA Following Definitive Local Therapy – Ongoing but no longer recruiting click here for more info

A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer – NCIC CTG PRC.3/CALGB 90203 - click here for more info

Canary Prostate Active Surveillance Study (PASS) - click here for more info

A Double-blind, Placebo-controlled Study to Evaluate New or Worsening Lens Opacifications in Subjects with Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss due to Androgen-Deprivation Therapy – Ongoing but no longer recruiting- click here for more info

A Phase 3 Randomized Double Blind Placebo-controlled study of Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients with Metastatic Castration Resistant Prostate Cancer - Ongoing but no longer recruiting

A Randomized, Double-Blind, Parallel, Placebo-Controlled, Phase 4, Multicenter Study to Assess Efficacy and Safety of VESIcare® (solifenacin succinate) to Improve Urinary Continence of Subjects afer Robotic Assisted Radical Prostatectomy - Opening to recruitment in early 2012 - click here for more info

Bladder cancer

A Phase I Clinical Trial Assessing Intravesical Antisense Oligonucleotide Targeting Heat Shock Protein 27 for the Treatment of Superficial Bladder Cancer - click here for more info

Overactive bladder

A 12 week, phase 3, randomized, double-blind, placebo controlled, parallel group, multicenter trial in overactive bladder subjects to confirm the efficacy of 8 mg fesoterodine compared to 4 mg fesoterodine - click here for more info

Kidney cancer

A Randomized, Double-Blind Phase III Trial of Adjuvant Sunitinib versus Sorafenib versus Placebo in Patients with Resected Renal Cell Carcinoma – NCIC REC.2 - Ongoing but no longer recruiting

Canadian Kidney Cancer Information System (CKCis) - a database project

A Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Pazopanib as Adjuvant Therapy for Subjects with Localized or Locally Advanced Renal Cell Cancer following Nephrectomy

Testicular cancer

The role of MRI in the Management of Retroperitoneal Lymph Node Metastasis in Patients with Testicular Cancer